Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome
• Myelogenous Leukemia

Drugs mentioned

• Clofarabine (Clolar) (clofarabine)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Leukemia, Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-04-25